Favorable Conditions in the U.S. Attract Preference for Growth in Cell Culture Market, According to BCC Research
May 27, 2015
Wellesley, Mass., May 27, 2015 –The market for cell culture products is undergoing growth due to greater demand for biopharmaceuticals, expanding research and development budgets, and growing supportive government policies. BCC Research reveals in its new report that the global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019, with a compound annual growth rate (CAGR) of 5.1% between 2014 and 2019.
The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune diseases and various infective diseases are key drivers of the market. As competition increases and new technologies emerge, new advancements and product launches should bolster market growth during the forecast period.
The U.S. remains the largest market comprising the three main products analyzed in the report—sera, media and reagents. The U.S. market totaled almost $1.3 billion in 2013 and should reach $1.6 billion in 2019, with a CAGR of 3.6%.
“The U.S. market, the world’s largest free-pricing market for pharmaceuticals, has a favorable patent and regulatory environment; therefore, success of a product is largely based on competition in product quality, safety, and efficacy and price,” says BCC Research analyst Shalini S. Dewan. “Support from the government for medical research, an unparalleled scientific and research base, and an innovative biotechnology sector are the major factors that make the U.S. market the preferred home for growth in the healthcare industry—which also includes biotechnology.”
Global Markets for Media, Sera and Reagents in Biotechnology (BIO014H) examines the cell culture products industry, applications in production, regulatory aspects, developments in cell culture techniques, and patent analysis and growth and restriction factors for the market.

![]()
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com
Global Markets for Media, Sera and Reagents in Biotechnology( BIO014H )
Publish Date: Mar 2015
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
- China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
- mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030
- Molecular Diagnostics Market to Grow at 13.1% CAGR Through 2030
- Biotech Equipment Market Projected to Reach $143.9 Billion Globally by 2030
Reports from Cell Biology
Recent News
- Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
- Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
- Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
- Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030
